Global Circulating Tumor Cells Competitive Landscape Professional Research Report 2025
Description
Global Circulating Tumor Cells Competitive Landscape Professional Research Report 2025
Research Summary
Circulating Tumor Cells (CTCs) are rare cancer cells that have detached from a solid tumor and entered the bloodstream, allowing them to circulate throughout the body. These cells play a significant role in cancer metastasis, as they can potentially seed new tumors in distant organs. CTCs can be isolated from a patient＇s blood sample and analyzed to provide valuable information about the cancer＇s progression, prognosis, and response to treatment. Detecting and analyzing CTCs is a non-invasive method that can help oncologists monitor disease progression and treatment effectiveness, and it may also guide treatment decisions for personalized therapies. While CTCs are a promising avenue for cancer research and personalized medicine, their rarity and heterogeneity pose challenges in their isolation and analysis. Nonetheless, ongoing advancements in technology and research are making CTC analysis increasingly important in cancer diagnosis and management.
According to DIResearch's in-depth investigation and research, the global Circulating Tumor Cells market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Circulating Tumor Cells include Menarini-Silicon Biosystems, Qiagen (Adnagen), Advanced Cell Diagnostics, ApoCell, Epic Sciences, Greiner Bio-one GmbH, Cynvenio, SurExamBio-Tech, Fluxion Biosciences, Ikonisys, Hangzhou Watson Biotech, Biocept, Guangzhou Wondfo Biotech, CytoTrack, Celsee, ANGLE plc, Clearbridge Biomedics etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Circulating Tumor Cells. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Circulating Tumor Cells market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Circulating Tumor Cells market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Circulating Tumor Cells industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Circulating Tumor Cells Include:
Menarini-Silicon Biosystems
Qiagen (Adnagen)
Advanced Cell Diagnostics
ApoCell
Epic Sciences
Greiner Bio-one GmbH
Cynvenio
SurExamBio-Tech
Fluxion Biosciences
Ikonisys
Hangzhou Watson Biotech
Biocept
Guangzhou Wondfo Biotech
CytoTrack
Celsee
ANGLE plc
Clearbridge Biomedics
Circulating Tumor Cells Product Segment Include:
CTC Enrichment
CTC Detection
CTC Analysis
Circulating Tumor Cells Product Application Include:
Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Circulating Tumor Cells Industry PESTEL Analysis
Chapter 3: Global Circulating Tumor Cells Industry Porter’s Five Forces Analysis
Chapter 4: Global Circulating Tumor Cells Major Regional Market Size and Forecast Analysis
Chapter 5: Global Circulating Tumor Cells Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Circulating Tumor Cells Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Circulating Tumor Cells Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Circulating Tumor Cells Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Circulating Tumor Cells Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Circulating Tumor Cells Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Circulating Tumor Cells Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Circulating Tumor Cells Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Circulating Tumor Cells Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Circulating Tumor Cells Product by Type
- 1.2.1 CTC Enrichment
- 1.2.2 CTC Detection
- 1.2.3 CTC Analysis
- 1.3 Circulating Tumor Cells Product by Application
- 1.3.1 Breast Cancer
- 1.3.2 Prostate Cancer
- 1.3.3 Colorectal Cancer
- 1.3.4 Lung Cancer
- 1.3.5 Others
- 1.4 Global Circulating Tumor Cells Market Size Analysis (2020-2032)
- 1.5 Circulating Tumor Cells Market Development Status and Trends
- 1.5.1 Circulating Tumor Cells Industry Development Status Analysis
- 1.5.2 Circulating Tumor Cells Industry Development Trends Analysis
- 2 Circulating Tumor Cells Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Circulating Tumor Cells Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Circulating Tumor Cells Market Analysis by Regions
- 4.1 Circulating Tumor Cells Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Circulating Tumor Cells Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Circulating Tumor Cells Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Circulating Tumor Cells Revenue Forecast by Region (2026-2032)
- 5 Global Circulating Tumor Cells Market Size by Type and Application
- 5.1 Global Circulating Tumor Cells Market Size by Type (2020-2032)
- 5.2 Global Circulating Tumor Cells Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Circulating Tumor Cells Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Circulating Tumor Cells Market Size by Type
- 6.4 North America Circulating Tumor Cells Market Size by Application
- 6.5 North America Circulating Tumor Cells Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Circulating Tumor Cells Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Circulating Tumor Cells Market Size by Type
- 7.4 Europe Circulating Tumor Cells Market Size by Application
- 7.5 Europe Circulating Tumor Cells Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Circulating Tumor Cells Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Circulating Tumor Cells Market Size by Type
- 8.4 China Circulating Tumor Cells Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Circulating Tumor Cells Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Circulating Tumor Cells Market Size by Type
- 9.4 APAC (excl. China) Circulating Tumor Cells Market Size by Application
- 9.5 APAC (excl. China) Circulating Tumor Cells Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Circulating Tumor Cells Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Circulating Tumor Cells Market Size by Type
- 10.4 Latin America Circulating Tumor Cells Market Size by Application
- 10.5 Latin America Circulating Tumor Cells Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Circulating Tumor Cells Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Circulating Tumor Cells Market Size by Type
- 11.4 Middle East & Africa Circulating Tumor Cells Market Size by Application
- 11.5 Middle East & Africa Circulating Tumor Cells Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Circulating Tumor Cells Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Circulating Tumor Cells Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Circulating Tumor Cells Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Menarini-Silicon Biosystems
- 13.1.1 Menarini-Silicon Biosystems Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Menarini-Silicon Biosystems Circulating Tumor Cells Product Portfolio
- 13.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Qiagen (Adnagen)
- 13.2.1 Qiagen (Adnagen) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Qiagen (Adnagen) Circulating Tumor Cells Product Portfolio
- 13.2.3 Qiagen (Adnagen) Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Advanced Cell Diagnostics
- 13.3.1 Advanced Cell Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Advanced Cell Diagnostics Circulating Tumor Cells Product Portfolio
- 13.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 ApoCell
- 13.4.1 ApoCell Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 ApoCell Circulating Tumor Cells Product Portfolio
- 13.4.3 ApoCell Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Epic Sciences
- 13.5.1 Epic Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Epic Sciences Circulating Tumor Cells Product Portfolio
- 13.5.3 Epic Sciences Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Greiner Bio-one GmbH
- 13.6.1 Greiner Bio-one GmbH Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Greiner Bio-one GmbH Circulating Tumor Cells Product Portfolio
- 13.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Cynvenio
- 13.7.1 Cynvenio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Cynvenio Circulating Tumor Cells Product Portfolio
- 13.7.3 Cynvenio Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 SurExamBio-Tech
- 13.8.1 SurExamBio-Tech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 SurExamBio-Tech Circulating Tumor Cells Product Portfolio
- 13.8.3 SurExamBio-Tech Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Fluxion Biosciences
- 13.9.1 Fluxion Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Fluxion Biosciences Circulating Tumor Cells Product Portfolio
- 13.9.3 Fluxion Biosciences Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Ikonisys
- 13.10.1 Ikonisys Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Ikonisys Circulating Tumor Cells Product Portfolio
- 13.10.3 Ikonisys Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Hangzhou Watson Biotech
- 13.11.1 Hangzhou Watson Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Hangzhou Watson Biotech Circulating Tumor Cells Product Portfolio
- 13.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Biocept
- 13.12.1 Biocept Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Biocept Circulating Tumor Cells Product Portfolio
- 13.12.3 Biocept Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 Guangzhou Wondfo Biotech
- 13.13.1 Guangzhou Wondfo Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Guangzhou Wondfo Biotech Circulating Tumor Cells Product Portfolio
- 13.13.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 CytoTrack
- 13.14.1 CytoTrack Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 CytoTrack Circulating Tumor Cells Product Portfolio
- 13.14.3 CytoTrack Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.15 Celsee
- 13.15.1 Celsee Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Celsee Circulating Tumor Cells Product Portfolio
- 13.15.3 Celsee Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.16 ANGLE plc
- 13.16.1 ANGLE plc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 ANGLE plc Circulating Tumor Cells Product Portfolio
- 13.16.3 ANGLE plc Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.17 Clearbridge Biomedics
- 13.17.1 Clearbridge Biomedics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.17.2 Clearbridge Biomedics Circulating Tumor Cells Product Portfolio
- 13.17.3 Clearbridge Biomedics Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Circulating Tumor Cells Industry Chain Analysis
- 14.2 Circulating Tumor Cells Industry Raw Material and Suppliers Analysis
- 14.2.1 Circulating Tumor Cells Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Circulating Tumor Cells Typical Downstream Customers
- 14.4 Circulating Tumor Cells Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
